As EWS–FLI1 includes the FLI1 Ets portion and some upstream regions, both RHA and YK-4-279 potentially directly bind the Ets domain, particularly as YK-4-279 also inhibits ERG and ETV1-mediated invasion in prostate cancer [63]. The gene discussed is ERG; the disease is prostate carcinoma.